Experimental data indicated that 24,000 copies/cell in B‐cell NHL cell lines was sufficient for Lonca‐induced cytotoxicity, and QSP modelling predicted that response to Lonca may be achieved in patients with CD19 expression as low as 1000 molecules/cell. This evidence concerns the gene CD19 and B-cell non-Hodgkin lymphoma.